Quantcast
Channel: Italy Headlines on One News Page [United States]
Viewing all articles
Browse latest Browse all 40166

Allergan's Semprana and CoLucid's Lasmiditan, Two Novel Acute Migraine Therapies, Will Drive Market Growth Through 2023

$
0
0
BURLINGTON, Mass., Nov. 20, 2014 /PRNewswire/ -- Decision Resources Group finds that the overall migraine market will grow from approximately $3 billion in 2013 to over $5 billion in 2023 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan, with an average... Reported by PR Newswire 16 hours ago.

Viewing all articles
Browse latest Browse all 40166

Trending Articles